Dyne Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
May 2 16:28 ET
Dyne Therapeutics | 8-K: Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 2 16:20 ET
Dyne Therapeutics | DEFA14A: Others
Apr 5 16:24 ET
Dyne Therapeutics | DEF 14A: Definitive information statements
Apr 5 16:20 ET
Dyne Therapeutics | 8-K: Current report
Mar 25 07:43 ET
Dyne Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Mar 5 08:22 ET
Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Mar 5 07:42 ET
Dyne Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 5 07:42 ET
Dyne Therapeutics | 8-K: Current report
Jan 5 00:00 ET
Dyne Therapeutics | 8-K: Current report
Jan 4 00:00 ET
Dyne Therapeutics | 8-K: Current report
Jan 3 00:00 ET
Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Third Quarter 2023 Financial Results and Provides Update on Significant Progress for ACHIEVE and DELIVER Trials and Upcoming Clinical Milestones
Oct 30, 2023 07:36 ET
Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
Aug 3, 2023 07:35 ET
Dyne Therapeutics | 8-K: Current report
May 25, 2023 16:30 ET
Dyne Therapeutics | 8-K: Dyne Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
May 11, 2023 07:35 ET
Dyne Therapeutics | DEFA14A: Others
Apr 7, 2023 16:20 ET
Dyne Therapeutics | DEF 14A: Definitive proxy statements
Apr 7, 2023 16:15 ET
Dyne Therapeutics | 8-K: Current report
Mar 10, 2023 12:50 ET
Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
Mar 2, 2023 07:35 ET
Dyne Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 2, 2023 07:27 ET
No Data
No Data